An Australian antitrust investigator who helped bring criminal cartel charges against Citigroup Inc and Deutsche Bank AG denied acting with “impropriety” when presented with communications between the regulator and informants’ lawyers, reported The New York Times.
The court testimony from Australian Competition and Consumer Commission (ACCC) enforcement director Michael Taylor on Monday points to a defense strategy questioning the integrity of an investigation that ended in charges of collusion during a A$2.5 billion ($1.67 billion) share sale in 2015.
In pre-trial hearings, lawyers for the investment banks and their client, retail lender Australia and New Zealand Banking Group Ltd (ANZ), have been trying to show witness statements by a third investment bank which worked on the deal, JPMorgan Chase, were tainted by coordination between JPMorgan’s lawyers and the authorities.
JPMorgan and its staff and ex-staff agreed to act as informants with the ACCC in exchange for immunity from prosecution, the court has previously heard.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan